UPPER AIRWAY SLEEP DISORDERS AND DENTAL TREATMENT
DOI:
https://doi.org/10.61841/h5m05s53Keywords:
Dental treatments, oral devices, tongue retaining device, mandibular advancementAbstract
In recent year's, about 3% of the middle-aged population suffers from daytime sleepiness and nighttime sleep interruptions; it may be due to upper airway sleep disorders (UASD). A UASD is the narrowing of the upper airway and results in disruptions of sleep, affects health and lifestyle, and less concentration in work. Most of the automobile and work accidents are due to sleeplessness. It can also cause critical medical conditions. Apnea is the complete cessation of breath, and hypopnea is a reduction in the airflow. Obstructive sleep apnea (OSA) affects 4% of males and 2% of females. In a normal person, airway space is free for air passage, and in a disordered person, the airway space is compromised, which makes it difficult for the passage of air. There are multifactorial factors that can cause UASD. They are the position of muscles and anatomical alterations. In supine, the muscles tensor veli palatini and genioglossus have decreased activity. Anatomical alterations such as posteriorly positioned maxilla and mandible, overerupted anterior teeth, large gonial angle, and long tongue may reduce the upper airway space. There are various treatments for UASD. Dental treatment options such as a tongue retaining device (TRD) and a mandibular advancement device. This study reviewed the dental treatment involved in the treatment of UASD, the surgical methods involved, and also the failure of dental treatment. Many snoring and OSA patients were successfully treated using dental devices. UASD is treated successfully using oral devices. Dental treatments are successful in treating mild to moderate OSA.
Downloads
References
[1] Ivanhoe JR, Cibirka RM, Lefebvre CA, Parr GR. Dental considerations in upper airway sleep disorders:
A review of the literature. The Journal of Prosthetic Dentistry 1999;82:685–98.
https://doi.org/10.1016/s0022-3913(99)70010-7.
[2] Findley LJ, Unverzagt ME, Surratt PM. Automobile accidents involving patients with obstructive sleep
apnea. Am Rev Respir Dis 1988;138:337–40. https://doi.org/10.1164/ajrccm/138.2.337.
[3] Guilleminault C, Stoohs R, Clerk A, Cetel M, Maistros P. A cause of excessive daytime sleepiness. The
upper airway resistance syndrome. Chest 1993;104:781–7. https://doi.org/10.1378/chest.104.3.781.
[4] Noureddine SN. Sleep apnea: A challenge in critical care. Heart & Lung 1996;25:37–42.
https://doi.org/10.1016/s0147-9563(96)80010-0.
[5] Rosen CL, D’Andrea L, Haddad GG. Adult criteria for obstructive sleep apnea do not identify children
with serious obstruction. Am Rev Respir Dis 1992;146:1231–4.
https://doi.org/10.1164/ajrccm/146.5_Pt_1.1231.
[6] Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and
theory. Am J Med 1995;98:118–28. https://doi.org/10.1016/S0002-9343(99)80395-7.
[7] Shukri NMM, Vishnupriya V, Gayathri R, Mohan SK. Awareness in childhood obesity. Research Journal
of Pharmacy and Technology 2016;9:1658. https://doi.org/10.5958/0974-360x.2016.00334.6.
[8] Rengasamy G, Venkataraman A, Veeraraghavan VP, Jainu M. Cytotoxic and apoptotic potential of
Myristica fragrans Houtt. (mace) extract on human oral epidermal carcinoma KB cell lines. Brazilian
Journal of Pharmaceutical Sciences 2018;54. https://doi.org/10.1590/s2175-97902018000318028.
[9] Menon A, V VP, Gayathri R. PRELIMINARY PHYTOCHEMICAL ANALYSIS AND
CYTOTOXICITY POTENTIAL OF PINEAPPLE EXTRACT ON ORAL CANCER CELL LINES.
Asian Journal of Pharmaceutical and Clinical Research 2016:140.
https://doi.org/10.22159/ajpcr.2016.v9s2.13313.
[10] Priya VV, Jainu M, Mohan SK. Biochemical Evidence for the Antitumor Potential of Linn. On
Diethylnitrosamine-Induced Hepatic Carcinoma. Pharmacogn Mag 2018;14:186–90.
https://doi.org/10.4103/pm.pm_213_17.
[11] Ma Y, Karunakaran T, Veeraraghavan VP, Mohan SK, Li S. Sesame Inhibits Cell Proliferation and
Induces Apoptosis through Inhibition of STAT-3 Translocation in Thyroid Cancer Cell Lines (FTC-133).
Biotechnology and Bioprocess Engineering 2019;24:646–52. https://doi.org/10.1007/s12257-019-0151-1.
[12] Gan H, Zhang Y, Zhou Q, Zheng L, Xie X, Veeraraghavan VP, et al. Zingerone induced caspase dependent apoptosis in MCF-7 cells and prevents 7,12-dimethylbenz(a)anthracene-induced mammary
carcinogenesis in experimental rats. J Biochem Mol Toxicol 2019;33:e22387.
https://doi.org/10.1002/jbt.22387.
[13] G R, Ramya G, V VP, Gayathri R. CYTOTOXICITY OF STRAWBERRY EXTRACT ON ORAL
CANCER CELL LINE. Asian Journal of Pharmaceutical and Clinical Research 2018;11:353.
https://doi.org/10.22159/ajpcr.2018.v11i9.25955.
[14] Ponnulakshmi R, Shyamala Devi B, Vijayalakshmi P, Selvaraj J. In silico and in vivo analysis to identify
the antidiabetic activity of beta-sitosterol in adipose tissue of high-fat diet and sucrose induced type-2
diabetic experimental rats. Toxicol Mech Methods 2019;29:276–90.
https://doi.org/10.1080/15376516.2018.1545815.
[15] Rengasamy, G., Jebaraj, D.M., Veeraraghavan, V.P., Mohan, S.K. Characterization, partial purification of
alkaline protease from the intestinal waste of Scomberomorus guttatus and production of laundry
detergent with alkaline protease additive. Indian Journal of Pharmaceutical Education and Research 2016.
https://doi.org/10.5530/ijper.50.2.19.
[16] Chen F, Tang Y, Sun Y, Veeraraghavan VP, Mohan SK, Cui C. 6-shogaol, and an active constituent of
ginger prevents UVB radiation mediated inflammation and oxidative stress through modulating NrF2
signaling in human epidermal keratinocytes (HaCaT cells). J Photochem Photobiol B 2019;197:111518.
https://doi.org/10.1016/j.jphotobiol.2019.111518.
[17] SURAPANENI KRISHNA MOHAN, VISHNU PRIYA VERRARAGHAVAN, MALLIKA JAINU.
EFFECT OF PIOGLITAZONE, QUERCETIN, AND HYDROXYCITRIC ACID ON
EXTRACELLULAR MATRIX COMPONENTS IN EXPERIMENTALLY INDUCED
NONALCOHOLIC STEATOHEPATITIS. Iran J Basic Med Sci 2015;18:832–6.
[18] Ke Y, Al Aboody MS, Al Turaiki W, Alsagaby SA, Alfaiz FA, Veeraraghavan VP, et al.
Photosynthesized gold nanoparticles from Catharanthus roseus induces caspase-mediated apoptosis in
cervical cancer cells (HeLa). Artif Cells Nanomed Biotechnol 2019;47:1938–46.
https://doi.org/10.1080/21691401.2019.1614017.
[19] Wu F, Zhu J, Li G, Wang J, Veeraraghavan VP, Mohan SK, et al. Biologically synthesized green gold
nanoparticles from Siberian ginseng induce a growth-inhibitory effect on melanoma cells (B16). Artificial
Cells, Nanomedicine, and Biotechnology 2019;47:3297–305.
https://doi.org/10.1080/21691401.2019.1647224.
[20] Wang Y, Zhang Y, Guo Y, Lu J, Veeraraghavan VP, Mohan SK, et al. Synthesis of Zinc oxide
nanoparticles from Marsdenia tenacissima inhibits the cell proliferation and induces apoptosis in laryngeal
cancer cells (Hep-2). J Photochem Photobiol B 2019;201:111624.
https://doi.org/10.1016/j.jphotobiol.2019.111624.
[21] Li Z, Veeraraghavan VP, Mohan SK, Bolla SR, Lakshmanan H, Kumaran S, et al. Apoptotic induction
and anti-metastatic activity of eugenol encapsulated chitosan nanopolymer on rat glioma C6 cells via
alleviating the MMP signaling pathway. J Photochem Photobiol B 2020;203:111773.
https://doi.org/10.1016/j.jphotobiol.2019.111773.
[22] Stadler DL, Doug McEvoy R, Bradley J, Paul D, Catcheside PG. Changes in lung volume and diaphragm
muscle activity at sleep onset in obese obstructive sleep apnea patients vs. healthy-weight controls.
Journal of Applied Physiology 2010;109:1027–36. https://doi.org/10.1152/japplphysiol.01397.2009.
[23] Mezzanotte WS, Tangel DJ, White DP. Waking genioglossal electromyogram in sleep apnea patients
versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 1992;89:1571–9.
https://doi.org/10.1172/JCI115751.
[24] Adachi S, Lowe AA, Tsuchiya M, Ryan CF, Fleetham JA. Genioglossus muscle activity and inspiratory
timing in obstructive sleep apnea. Am J Orthod Dentofacial Orthop 1993;104:138–45.
https://doi.org/10.1016/S0889-5406(05)81003-0.
[25] Waldhorn RE. Sleep apnea syndrome. Am Fam Physician 1985;32:149–66.
[26] Pae EK, Lowe AA, Sasaki K, Price C, Tsuchiya M, Fleetham JA. A cephalometric and electromyographic
study of upper airway structures in the upright and supine positions. Am J Orthod Dentofacial Orthop
1994;106:52–9. https://doi.org/10.1016/S0889-5406(94)70021-4.
[27] Sériès F. Evaluation of treatment efficacy in sleep apnea-hypopnea syndrome. Sleep 1996;19:S71–6.
https://doi.org/10.1093/sleep/19.suppl_9.s71.
[28] The International Classification of Sleep Disorders. By the American Sleep Disorders Association. (Pp.
396; 59.95 hb, 49.95 PB.) American Sleep Disorders Association: Rochester, MN. 1990. Psychological
Medicine 1991;21:1079–1079. https://doi.org/10.1017/s0033291700030117.
[29] Ferguson KA, Ono T, Lowe AA, Keenan SP, Fleetham JA. A randomized crossover study of an oral
appliance vs nasal-continuous positive airway pressure in the treatment of mild-moderate obstructive sleep
apnea. Chest 1996;109:1269–75. https://doi.org/10.1378/chest.109.5.1269.
[30] Man GC. Obstructive sleep apnea. Diagnosis and treatment. Med Clin North Am 1996;80:803–20.
https://doi.org/10.1016/s0025-7125(05)70468-5.
[31] Chaudhary BA, Smith JK. Obstructive sleep apnea syndrome. J Med Assoc Ga 1991;80:541–5.
[32] Schwab RJ. Properties of tissues surrounding the upper airway. Sleep 1996;19:S170–4.
https://doi.org/10.1093/sleep/19.suppl_10.170.
[33] Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing
among middle-aged adults. N Engl J Med 1993;328:1230–5.
https://doi.org/10.1056/NEJM199304293281704.
[34] Clark GT, Nakano M. Dental appliances for the treatment of obstructive sleep apnea. The Journal of the
American Dental Association 1989;118:611–9. https://doi.org/10.14219/jada.archive.1989.0086.
[35] Boudewyns AN, Van de Heyning PH. Obstructive sleep apnea syndrome in children: an overview. Acta
Otorhinolaryngol Belg 1995;49:275–9.
[36] Lowe AA, Santamaria JD, Fleetham JA, Price C. Facial morphology, and obstructive sleep apnea. Am J
Orthod Dentofacial Orthop 1986;90:484–91. https://doi.org/10.1016/0889-5406(86)90108-3.
[37] Lowe AA, Fleetham JA, Adachi S, Ryan CF. Cephalometric and computed tomographic predictors of
obstructive sleep apnea severity. Am J Orthod Dentofacial Orthop 1995;107:589–95.
https://doi.org/10.1016/s0889-5406(95)70101-x.
[38] Ryan CF, Lowe AA, Li D, Fleetham JA. Three-dimensional upper airway computed tomography in
obstructive sleep apnea. A prospective study in patients treated by uvulopalatopharyngoplasty. Am Rev
Respir Dis 1991;144:428–32. https://doi.org/10.1164/ajrccm/144.2.428.
[39] Barsh LI. Responsibilities of the dental profession in recognizing and treating sleep breathing disorders.
Compend Contin Educ Dent 1996;17:490–4, 496 passim; quiz 502.
[40] Cartwright RD, Samelson CF. The effects of a nonsurgical treatment for obstructive sleep apnea. The
tongue-retaining device. JAMA 1982;248:705–9.
[41] Ryan CF, Love LL, Peat D, Fleetham JA, Lowe AA. Mandibular advancement oral appliance therapy for
obstructive sleep apnoea: effect on the awake caliber of the velopharynx. Thorax 1999;54:972–7.
https://doi.org/10.1136/thx.54.11.972.
[42] Robin P. GLOSSOPTOSIS DUE TO ATRESIA AND HYPOTROPHY OF THE MANDIBLE. Archives
of Pediatrics & Adolescent Medicine 1934;48:541.
https://doi.org/10.1001/archpedi.1934.01960160063005.
[43] Schmidt-Nowara W, Lowe A, Wiegand L, Cartwright R, Perez-Guerra F, Men’s. Oral appliances for the
treatment of snoring and obstructive sleep apnea: a review. Sleep 1995;18:501–10.
https://doi.org/10.1093/sleep/18.6.501.
[44] Mohan SK, Veeraraghavan VP, Jainu M. Effect of pioglitazone, quercetin, and hydroxy citric acid on
extracellular matrix components in experimentally induced non-alcoholic steatohepatitis. Iran J Basic Med
Sci 2015;18:832–6.
[45] Practice parameters for the treatment of obstructive sleep apnea in adults: the efficacy of surgical
modifications of the upper airway. Report of the American Sleep Disorders Association. Sleep
1996;19:152–5.
[46] Deutsch ES. Tonsillectomy and adenoidectomy. Changing indications. Pediatr Clin North Am
1996;43:1319–38. https://doi.org/10.1016/s0031-3955(05)70521-6.
[47] Sériès F, St. Pierre S, Carrier G. Effects of Surgical Correction of Nasal Obstruction in the Treatment of
Obstructive Sleep Apnea. American Review of Respiratory Disease 1992;146:1261–5.
https://doi.org/10.1164/ajrccm/146.5_pt_1.1261.
[48] Bear SE, Priest JH. Sleep apnea syndrome: correction with surgical advancement of the mandible. J Oral
Surg 1980;38:543–9.
[49] Masumi S, Nishizawa K, Williams AJ, Yan-Go FL, Clark GT. Effect of jaw position and posture on
forced inspiratory airflow in normal subjects and patients with obstructive sleep apnea. Chest
1996;109:1484–9. https://doi.org/10.1378/chest.109.6.1484.
[50] Riley RW, Powell NB, Guilleminault C, Nino-Murcia G. Maxillary, mandibular, and hyoid advancement:
an alternative to tracheostomy in obstructive sleep apnea syndrome. Otolaryngol Head Neck Surg
1986;94:584–8. https://doi.org/10.1177/019459988609400509.
[51] Riley RW, Powell NB, Guilleminault C. Maxillofacial surgery and nasal CPAP. A comparison of
treatment for obstructive sleep apnea syndrome. Chest 1990;98:1421–5.
https://doi.org/10.1378/chest.98.6.1421.
[52] Lee WC, Skinner DW, Prichard AJN. Complications of palatoplasty for snoring or sleep apnoea. The
Journal of Laryngology & Otology 1997;111:1151–4. https://doi.org/10.1017/s002221510013957x.
Downloads
Published
Issue
Section
License
Copyright (c) 2020 AUTHOR
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
